Exhibitions, New Solutions, Healthcare Initiatives, Acquisitions, and Peer-Reviewed Studies - Research Report on Mindray, Allscripts, BD, Teleflex, and West Pharmaceutical
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, November 1, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Mindray Medical International Limited (NYSE: MR), Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX), Becton, Dickinson and Company (NYSE: BDX), Teleflex Incorporated (NYSE: TFX), and West Pharmaceutical Services, Inc. (NYSE: WST). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Mindray Medical International Limited Research Report
On October 22, 2013, Mindray Medical International Limited (Mindray) announced that it will exhibit its latest products at two of the world's largest medical equipment trade events: the 70th China International Medical Equipment Fair (November 3-6, 2013 at Xiamen, China) and MEDICA 2013 (November 20-23, 2013 at Dusseldorf, Germany). Mindray stated that it will showcase new, innovative products from its three primary business segments i.e. patient monitoring and life support, in-vitro diagnostic, and medical imaging systems at both events. The Full Research Report on Mindray Medical International Limited - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/8d4d_MR]
--
Allscripts Healthcare Solutions, Inc. Research Report
On October 25, 2013, Allscripts Healthcare Solutions, Inc. (Allscripts) reported that Baylor Health Care System has upgraded to Allscripts Sunrise Clinicals 6.1, an integrated Electronic Health Record solution, which is certified in accordance with the 2014 certification criteria supporting the Meaningful Use Stage 2 measures. The Company stated that Allscripts Sunrise Clinicals 6.1 is an advanced clinical information solution that integrates inpatient and ambulatory care through a single, enterprise-wide EHR. Paul M. Black, President and CEO of Allscripts, commented, "Congratulations to all at Baylor on completing the upgrade to Allscripts Sunrise Clinicals 6.1. Sunrise Clinicals 6.1 will facilitate Meaningful Use 2 certification, and with increased power and functionality will support Baylor Health Care System as it drives positive outcomes and delivers the best possible care for patients." The Full Research Report on Allscripts Healthcare Solutions, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/1787_MDRX]
--
Becton, Dickinson and Company Research Report
On October 28, 2013, Becton, Dickinson and Company (BD), along with Direct Relief and the National Association of Community Health Centers, launched BD Helping Build Healthy Communities[SM], a four-year initiative that will expand access and improve care for underserved and vulnerable populations in the U.S. The Company informed that the initiative includes a BD commitment of approximately $5 million in cash and product to clinics and community health centers employing innovative models of care, along with strategic support from all partners. Vincent A. Forlenza, Chairman, CEO, and President of BD stated, "Clinics and community health centers all over the country provide critical services for millions of uninsured and under-insured Americans, but they face significant resource constraints. We are excited and proud to be working with Direct Relief and the National Association of Community Health Centers to help address some of these constraints and enable centers to continue delivering innovative care to underserved communities." The Full Research Report on Becton, Dickinson and Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/0175_BDX]
--
Teleflex Incorporated Research Report
On October 29, 2013, Teleflex Inc. (Teleflex) announced that it has entered into a definitive agreement to acquire privately-held Vidacare Corp. (Vidacare), a provider of intraosseous or inside the bone, access devices. Benson Smith, Teleflex Chairman, President, and CEO, said, "The acquisition of Vidacare, an industry leader with a high gross margin profile, will expand our comprehensive vascular access product portfolio with a defining technology that can provide either a bridge to longer term access devices such as a central venous catheter, or a rapid, less expensive, and lower risk alternative for difficult vascular access when long-term central lines are not necessary." Teleflex stated that the transaction is valued at $262.5 million, and is expected to be completed late in Q4 2013. The Full Research Report on Teleflex Incorporated - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/9c7d_TFX]
--
West Pharmaceutical Services, Inc. Research Report
On October 29, 2013, West Pharmaceutical Services, Inc. (West) announced the first peer-reviewed data showing the benefits of Daikyo Crystal Zenith vials for the synthesis of radiopharmaceutical products. West stated that the study compared the effectiveness of container closure systems made from the Daikyo Crystal Zenith cyclic olefin polymer to glass for peptide-labeled radiopharmaceuticals. Amongst many key findings, the study showed that container closure systems made of Crystal Zenith had less product adherence to vials compared to single-use glass vials. Vinod Vilivalam, Ph.D., Senior Director of Global Technical Marketing Daikyo-West Products, stated, "This study is an important addition to the growing body of evidence showing Crystal Zenith container closure systems are an effective alternative to glass, especially in emerging areas of cell therapy and radiopharmaceuticals." The Full Research Report on West Pharmaceutical Services, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/39a2_WST]
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
AnalystsCorner.com
SOURCE Analysts' Corner
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article